Servizi e Laboratori » Ambulatorio per la Diagnosi e la terapia del Morbo di Parkinson » Pubblicazioni

• Rango M, Bozzali M, Prelle A, Scarlato G, Bresolin N.
  Brain activation in normal subjects and in patients affected by mitochondrial disease without clinical central nervous system involvement: a phosphorus magnetic resonance spectroscopy study.
  J Cereb Blood Flow Metab. 2001 Jan;21(1):85-91. PMID: 11149672 [PubMed - indexed for MEDLINE]
  
• Rango M, Castelli A, Scarlato G.
  Energetics of 3.5 s neural activation in humans: a 31P MR spectroscopy study.
  Magn Reson Med. 1997 Dec;38(6):878-83. PMID: 9402187 [PubMed - indexed for MEDLINE]
  
• Rango M, Spagnoli D, Tomei G, Bamonti F, Scarlato G, Zetta L.
  Central nervous system trans-synaptic effects of acute axonal injury: a 1H magnetic resonance spectroscopy study.
  Magn Reson Med. 1995 May;33(5):595-600. PMID: 7596262 [PubMed - indexed for MEDLINE]
  
• Rango M, Lenkinski RE, Alves WM, Cruz J, Gennarelli TA.
  Brain pH in acute head injury.Minerva Anestesiol. 1993 Dec;59(12):835-6.
  No abstract available.
  PMID: 8177434 [PubMed - indexed for MEDLINE]
  
• Rango M, Lenkinski RE, Alves WM, Gennarelli TA.
  Brain pH in head injury: an image-guided 31P magnetic resonance spectroscopy study.
  Ann Neurol. 1990 Nov;28(5):661-7.
  PMID: 2260853 [PubMed - indexed for MEDLINE]
  
• Rango M, Candelise L, Perani D, Messa C, Scarlato G, Canal N, Franceschi M, Fazio F.
  Cortical pathophysiology and clinical neurologic abnormalities in acute cerebral ischemia. A serial study with single photon emission computed tomography.
  Arch Neurol. 1989 Dec;46(12):1318-22.
  PMID: 2590016 [PubMed - indexed for MEDLINE]
  
• Rango M, Farabola M, Canesi M, et al.
  Parkinson's disease, exposure to toxic substances and basal nuclei.
  RIV NEURORADIOL 14: 47-48 Suppl. 3 DEC 2001
  
• Rango M, Bozzali M, Prelle A, et al.
  Brain activation in normal subjects and in patients affected by mitochondrial disease without clinical central nervous system involvement: A phosphorus magnetic resonance spectroscopy study.
  J CEREBR BLOOD F MET 21 (1): 85-91 JAN 2001
  
• Rango M, Righini A, Farabola M, et al.
  Parkinson's disease, toxic exposure, and basal ganglia: A proton magnetic resonance spectroscopy study.
  NEUROLOGY 54 (7): A445-A445 Suppl. 3 APR 11 2000
  
• Rango M, Bozzali M, Castelli A, et al.
  Brain lactate and high energy phosphates in patients with mitochondrial disease without central nervous system involvement: A magnetic resonance spectroscopy-brain activation study.
  NEUROLOGY 52 (6): A158-A158 Suppl. 2 APR 1999
  
• Bozzali M, Rango M, Prelle A, et al.
  Brain activation in patients with mitochondrial disease without central nervous system involvement: A 31 P magnetic resonance spectroscopy study.
  NEUROLOGY 50 (4): P01039 Suppl. 4 APR 1998
  
• Rango M, Castelli A, Scarlato G
  Energetics of 3.5 s neural activation in humans: a P-31 MR spectroscopy study.
  MAGNET RESON MED 38 (6): 878-883 DEC 1997
  
• Rango M, Spagnoli D, Tomei G, et al.
  Central-Nervous-System transsynaptic effects of acute axonal injury - A H-1 magnetic-resonance spectroscopy study.
  MAGNET RESON MED 33 (5): 595-600 MAY 1995
  
• Rango M, Lenkinski Re, Alves Wm, et al.
  Brain ph in head-injury - an image-guided p-31 magnetic-resonance spectroscopy study .
  ANN NEUROL 28 (5): 661-667 NOV 1990
  
• Greenberg Jh, Kushner M, Rango M, et al.
  Validation studies of iodine-123-iodoamphetamine as a cerebral blood-flow tracer using emission tomography.
  J NUCL MED 31 (8): 1364-1369 AUG 1990
  
• Kushner M, Nencini P, Reivich M, Rango M et al.
  Relation of hyperglycemia early in ischemic brain infarction to cerebral anatomy, metabolism, and clinical outcome
  ANN NEUROL 28 (2): 129-135 AUG 1990